Search results for "COPD"
MKSAP Quiz: Posthospital evaluation for severe COPD
A 64-year-old woman is evaluated during a posthospital visit for severe COPD with an FEV1 of 30% of predicted. She has been admitted three times during the last year with acute exacerbations. Following physical and pulmonary exams, what is the most appropriate treatment to reduce this patient's COPD exacerbations?
https://immattersacp.org/weekly/archives/2019/08/20/3.htm
20 Aug 2019
New diabetes drug, LABA for COPD, skin antibiotic approved
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and skin-structure infections.
https://immattersacp.org/archives/2014/10/fda.htm
1 Oct 2014
Task Force recommends against screening for COPD
The recommendation applies to asymptomatic adults, defined as those who do not recognize or report respiratory symptoms.
https://immattersacp.org/weekly/archives/2016/04/12/4.htm
12 Apr 2016
Triple inhaler therapy associated with reduced COPD exacerbations, higher rates of pneumonia
Results of the systematic review and meta-analysis suggest that triple inhaler therapy should be limited to patients with more severe symptoms of chronic obstructive pulmonary disease (COPD) that cannot be adequately managed by dual therapy, the authors said.
https://immattersacp.org/weekly/archives/2018/11/13/2.htm
13 Nov 2018
New drugs approved for type 2 diabetes and COPD
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014
Guidance on using rapid tests, managing COPD, and screening for cardiac problems in COVID-19
The FDA warned about false positives with rapid tests, guidance addressed care for chronic obstructive pulmonary disease (COPD) during the pandemic, and experts advised on ethics of emergency use authorizations, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2020/11/10/1.htm
10 Nov 2020
Helping more patients quit smoking
Asking patients about smoking and advising them to quit is not enough to set them up for success.
https://immattersacp.org/archives/2022/06/helping-more-patients-quit-smoking.htm
1 Jun 2022
MKSAP Quiz: Follow-up for severe COPD
A 55-year-old man is evaluated in follow-up for severe COPD, which was diagnosed 2 years ago. He has had two exacerbations in the past year requiring hospitalization, and his baseline exercise tolerance is low. Following a physical exam and other tests, what is most likely to benefit this patient?
https://immattersacp.org/weekly/archives/2018/08/14/3.htm
14 Aug 2018
Guideline offers recommendations to prevent acute COPD exacerbations
An evidence-based guideline from the American College of Chest Physicians and Canadian Thoracic Society offers recommendations on preventing exacerbations in patients with chronic obstructive pulmonary disease (COPD).
https://immattersacp.org/weekly/archives/2015/04/14/2.htm
14 Apr 2015
New drugs approved for hypertension, lupus and COPD
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/05/fda.htm
1 May 2011